eHealth Board Member Dale Wolf Expands Stake with Annual Stock Grant

Rhea-AI Filing Summary

eHealth Director Dale B. Wolf reported the acquisition of 34,574 restricted stock units (RSUs) on June 17, 2025, as part of the company's annual non-employee director compensation. The RSUs were granted at $0 cost and will vest in four equal quarterly installments starting from the grant date.

Key details of the transaction:

• Following the transaction, Wolf directly owns 123,133 shares of common stock
• Additionally holds 62,932 shares indirectly through the Dale B. Wolf Generation Skipping Trust
• RSUs will vest fully if either: (1) the day before next annual stockholder meeting, or (2) upon a Change in Control
• Vesting is contingent on continued service as defined in the 2024 Equity Incentive Plan

This Form 4 filing, signed by attorney-in-fact Sonwha Lee on June 20, 2025, demonstrates standard board compensation practices and aligns director interests with shareholders through equity-based awards.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider WOLF DALE B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	34,574	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 123,133 shares (Direct); Common Stock — 62,932 shares (Indirect, By Trust)

Footnotes (1)

1. This represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs vest in four equal quarterly installments from the vesting commencement date of June 17, 2025, subject to the individual's continued status as a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan (the "Plan")) through the applicable vesting date; provided, however, that any then-unvested RSUs shall vest in full (i) on the day immediately prior to the date of the Issuer's next annual stockholder meeting or (ii) if the Issuer is subject to a Change in Control (as defined in the Plan), subject in each case to the individual's continued status as a Service Provider through such vesting date. Shares held by the Dale B. Wolf Generation Skipping Trust.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WOLF DALE B

(Last) (First) (Middle)

C/O EHEALTH, INC.

13620 RANCH ROAD 620 N, SUITE A250

(Street)

AUSTIN TX 78717

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
eHealth, Inc. [ EHTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/17/2025		A		34,574(1)	A	$0	123,133	D
Common Stock								62,932	I	By Trust(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs vest in four equal quarterly installments from the vesting commencement date of June 17, 2025, subject to the individual's continued status as a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan (the "Plan")) through the applicable vesting date; provided, however, that any then-unvested RSUs shall vest in full (i) on the day immediately prior to the date of the Issuer's next annual stockholder meeting or (ii) if the Issuer is subject to a Change in Control (as defined in the Plan), subject in each case to the individual's continued status as a Service Provider through such vesting date.

2. Shares held by the Dale B. Wolf Generation Skipping Trust.

Remarks:

	/s/ Sonwha Lee as attorney-in-fact for Dale B. Wolf	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many EHTH restricted stock units (RSUs) did Director Dale Wolf receive on June 17, 2025?

Director Dale Wolf received 34,574 restricted stock units (RSUs) as part of his annual non-employee director compensation on June 17, 2025. Each RSU represents a contingent right to receive one share of eHealth's common stock upon vesting.

What is the vesting schedule for EHTH Director Dale Wolf's 2025 RSU grant?

The RSUs vest in four equal quarterly installments starting from June 17, 2025. However, any unvested RSUs will fully vest either (1) the day before eHealth's next annual stockholder meeting or (2) if the company undergoes a Change in Control, subject to Wolf's continued service as a director.

How many shares of EHTH stock does Dale Wolf own directly and indirectly as of June 2025?

Following the RSU grant, Dale Wolf owns 123,133 shares of EHTH stock directly and 62,932 shares indirectly through the Dale B. Wolf Generation Skipping Trust, for a total beneficial ownership of 186,065 shares.

What was the purchase price of EHTH RSUs granted to Director Dale Wolf in June 2025?

The RSUs were granted to Dale Wolf at a price of $0 as part of his non-employee director compensation package, according to the Form 4 filing dated June 20, 2025.